JD Health International Inc. (HKG:6618)
Hong Kong
· Delayed Price · Currency is HKD 46.56
+1.82 (4.07%)
Apr 29, 2026, 4:08 PM HKT
JD Health International Revenue
In the year 2025, JD Health International had annual revenue of 73.44B CNY with 26.28% growth. JD Health International had revenue of 38.15B in the half year ending December 31, 2025, with 44.41% growth.
Revenue
73.44B CNY
Revenue Growth
+26.28%
P/S Ratio
1.83
Revenue / Employee
13.95M CNY
Employees
5,263
Market Cap
149.49B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Alibaba Health Information Technology | 36.09B |
| YSB Inc. | 23.34B |
| Shanghai Pioneer Holding | 1.43B |
| Fangzhou | 3.92B |
| Kingworld Medicines Group | 1.02B |
| Tycoon Group Holdings | 1.10B |
| China Healthwise Holdings | 99.56M |
| Pa Shun International Holdings | 96.60M |
JD Health International News
- 2 years ago - ‘The China equity trade is back' and here are the stocks to pick, says SocGen - Market Watch